Latarcin-3a (5-17) [M5,13L; K10A; E11,14K; L16A; K17L]
General Information
DRACP ID DRACP04464
Peptide Name Latarcin-3a (5-17) [M5,13L; K10A; E11,14K; L16A; K17L]
Sequence LAKKLAKYLKKAL
Sequence Length 13
UniProt ID Q1ELU3
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C72H130N18O15
Absent amino acids CDEFGHIMNPQRSTVW
Common amino acids K
Mass 170218
Pl 11.02
Basic residues 5
Acidic residues 0
Hydrophobic residues 7
Net charge 5
Boman Index -278
Hydrophobicity -1.54
Aliphatic Index 143.08
Half Life
Mammalian: 5.5 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 1490
Absorbance 280nm 124.17
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 36212827
Title First generation of multifunctional peptides derived from latarcin-3a from聽Lachesana tarabaevi聽spider toxin
Doi Not available
Year 2022
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 20024